CAS 745013-59-6

Tremelimumab

CAS: 745013-59-6

Tremelimumab, a CTLA-4 blocker, is used with Durvalumab to treat solid tumors like liver and lung cancer.

Reinheit: SDS-PAGE:95.4%;SEC-HPLC:98.7%

Farbe und Form: Liquid

Molekulargewicht: 146.3 kDa

Ref: TM-T77466

Tremelimumab

CAS: 745013-59-6

Anti-Human CTLA4 Monoclonal Antibody

Ref: 3D-CLA1189